Hepatocellular Carcinoma, An Issue of Surgical Oncology Clinics of North America, 1st Edition
Author :
Edited by Adam C. Yopp, MD and Maria B. Majella Doyle, MD, MBA, FRCS
In this issue of Surgical Oncology Clinics, guest editors Drs. Adam Yopp and Maria B. Majella Doyle bring their considerable expertise to the topic of Hepatocellular Carcinoma. Top experts in the field explore promising recent advances in the treatme
...view more
In this issue of Surgical Oncology Clinics, guest editors Drs. Adam Yopp and Maria B. Majella Doyle bring their considerable expertise to the topic of Hepatocellular Carcinoma. Top experts in the field explore promising recent advances in the treatment of all stages of hepatocellular carcinoma (HCC), neoadjuvant or downstaging therapy, the role of LI-RADS in hepatocellular carcinoma, surveillance of hepatocellular carcinoma, liver transplantation, and more.
In this issue of Surgical Oncology Clinics, guest editors Drs. Adam Yopp and Maria B. Majella Doyle bring their considerable expertise to the topic of Hepatocellular Carcinoma. Top experts in the field explore promising recent advances in the treatment of all stages of hepatocellular carcinoma (HCC), neoadjuvant or downstaging therapy, the role of LI-RADS in hepatocellular carcinoma, surveillance of hepatocellular carcinoma, liver transplantation, and more.
Key Features
Contains 13 relevant, practice-oriented topics, including the changing epidemiology of HCC within the US and worldwide; HCC surveillance: evidence-based tailored approach; surgical resection outside early stage HCC; minimally invasive techniques for HCC resection; overview of current HCC staging systems: is there an optimal system?; and more.
Provides in-depth clinical reviews on hepatocellular carcinoma, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Adam C. Yopp, MD, Chief, Division of Surgical Oncology, UT Southwestern Medical Center and Maria B. Majella Doyle, MD, MBA, FRCS, Professor of Surgery, Mary Culver Department of Surgery, Washington University School of Medicine
Edited by Adam C. Yopp, MD, Chief, Division of Surgical Oncology, UT Southwestern Medical Center and Maria B. Majella Doyle, MD, MBA, FRCS, Professor of Surgery, Mary Culver Department of Surgery, Washington University School of Medicine
Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide Hepatocellular Carcinoma Surveillance: Evidence-Based Tailored Approach Overview of Current Hepatocellular Carcinoma Staging Systems: Is There an Optimal System? Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma Up-to-Date Role of Liver Imaging Reporting and Data System in Hepatocellular Carcinoma Evolution of Systemic Therapy in Advanced Hepatocellular Carcinoma Role of Neoadjuvant Therapy Prior to Curative Resection in Hepatocellular Carcinoma Expanding Indications for Surgical Resection in Hepatocellular Carcinoma: What is the Evidence? Minimally Invasive Robotic Techniques for Hepatocellular Carcinoma Resection: How I Do It Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma Downstaging Hepatocellular Carcinoma before Transplantation: Role of Immunotherapy Versus Locoregional Approaches Management of Intermediate-Stage Hepatocellular Carcinoma: Systemic Versus Locoregional Therapy Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma
https://www.asia.elsevierhealth.com/hepatocellular-carcinoma-an-issue-of-surgical-oncology-clinics-of-north-america-9780443183966.html308283Hepatocellular Carcinoma, An Issue of Surgical Oncology Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/https://www.asia.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png74.2498.99USDInStock/Medicine/Surgery/Clinics/Health Professions/Complementary & Alternative Medicine/Japan Titles/Clinics/Clinics505458352550415259868526316050546664388725148865365054553514512052598384182692In this issue of <i>Surgical Oncology Clinics</i>, guest editors Drs. Adam Yopp and Maria B. Majella Doyle bring their considerable expertise to the topic of <b>Hepatocellular Carcinoma</b>. Top experts in the field explore promising recent advances in the treatment of all stages of hepatocellular carcinoma (HCC), neoadjuvant or downstaging therapy, the role of LI-RADS in hepatocellular carcinoma, surveillance of hepatocellular carcinoma, liver transplantation, and more. In this issue of <i>Surgical Oncology Clinics</i>, guest editors Drs. Adam Yopp and Maria B. Majella Doyle bring their considerable expertise to the topic of <b>Hepatocellular Carcinoma</b>. Top experts in the field explore promising recent advances in the treatment of all stages of hepatocellular carcinoma (HCC), neoadjuvant or downstaging therapy, the role of LI-RADS in hepatocellular carcinoma, surveillance of hepatocellular carcinoma, liver transplantation, and more.00add-to-cart97804431839662023ProfessionalEdited by Adam C. Yopp, MD and Maria B. Majella Doyle, MD, MBA, FRCS20241Book152w x 229h (6.00" x 9.00")Elsevier240Nov 10, 2023IN STOCKEdited by <STRONG>Adam C. Yopp</STRONG>, MD, Chief, Division of Surgical Oncology, UT Southwestern Medical Center and <STRONG>Maria B. Majella Doyle</STRONG>, MD, MBA, FRCS, Professor of Surgery, Mary Culver Department of Surgery, Washington University School of MedicineClinicsClinicsThe Clinics: SurgeryUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
